University of Kansas

Fairway, Kansas 66205

4 studies enrolling now · 13 studies all time

What they study most

Acute Myeloid Leukemia (AML), Advanced Breast Cancer, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Ovarian Carcinoma, Advanced Solid Tumor, Advanced Solid Tumors, Alzheimer Disease, Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis, CCNE1 Amplification, Cognition Disorders

Studies at this site

• Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors — Recruiting now
• Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS — Recruiting now
• A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors — Recruiting now
• APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML — Recruiting now
• Alzheimer's Disease Neuroimaging Initiative 4 — Enrolling by invitation
• A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202) — Running, not enrolling
• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid — Running, not enrolling
• Alzheimer's Disease Neuroimaging Initiative 3 — Completed
• Alzheimer's Plasma Extension — Running, not enrolling
• TRC-PAD Program: In-Clinic Trial-Ready Cohort — Completed
• Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study — Completed
• A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids — Stopped early
• A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer — Stopped early